SGLT2 inhibitor empagliflozin is shown to be safe and effective for treating patients who have suffered a heart attack EurekAlert Nawigacja wpisu Opinion | We Know Mental Health Affects Physical Health. Why Don’t We Act Like It? – The New York Times Health + Tech | Fusing tradition and technology – Jamaica Gleaner
